← Leaderboards
Jean-Philippe Julien
State University Of New York At Buffalo
$1,339,335
Attributed
$2,956,026
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $832.1K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,956,026 · 2
By mechanism
R01$2,956,026 · 2
Top collaborators
- Jonathan F Lovell5 shared
- Stefan H.I. Kappe1 shared
- D. Noah Sather1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Jonathan F Lovell$9,226,863
- Joseph P Balthasar$10,000,685
- Andres Obregon$1,173,856
- Zhen Yan$22,366,472
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseTransmission ProcessMonoclonal AntibodiesRecombinantsTechnologyTransmission-Blocking VaccineGlycosylationMalariaNovel VaccinesProteinsCulicidaeStructureAntibodiesEpitopesDesignGerm CellsImmunogenicityBlocking AntibodiesAntibody ResponseNext GenerationParasitesPlasmodium FalciparumAntigensVaccination
Grant awards (6)
Species-transcending prevention of mosquito vector infection$832,071
R01 · FY2025 · AI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392,026
R01 · FY2024 · AI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$455,639
R01 · FY2023 · AI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392,026
R01 · FY2022 · AI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392,026
R01 · FY2021 · AI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$492,238
R01 · FY2020 · AI